Michael Schweizer, MD

Physician
Seattle Cancer Care Alliance
Assistant Professor, Division of Medical Oncology
University of Washington School of Medicine
Associate Professor, Clinical Research Division
Fred Hutchinson Cancer Research Center
Specialty:
Medical Oncology
“My goal is to provide the absolute best patient care, driven by state-of-the-art science and a compassionate, empathetic approach. I work closely with each of my patients to ensure that they have the information they need to make the best treatment decisions. I strive to explore every option available so that my patients can find the approach that works best for them–empowering them to take control of their disease.”
— Dr. Schweizer
Why do you practice oncology?

Michael Schweizer, MD, decided to work in health care because he wanted to feel intellectually challenged in his career and, more importantly, he wanted to do something that would allow him to help people. Medicine was the perfect fit. “Early on in my training, I realized that you often see the best in people when they are faced with a cancer diagnosis,” Dr. Schweizer said. “The hope that my patients have in spite of being diagnosed with such serious illnesses is inspiring. It’s my patients’ hope that motivates me and makes me want to be a part of working toward cures.” Dr. Schweizer’s research involves translational genitourinary cancer. “My goal is to help reduce the morbidity and mortality associated with diseases like prostate cancer through developing novel drug therapies. Cancer is a formidable foe, but one that I believe we can vanquish. I hope to be a part of bringing the dream of a world without cancer into reality. I hope to see cancer cured in my lifetime.” Outside of work, Dr. Schweizer enjoys cooking, hiking, and spending time with his wife and two children.

Schweizer-secondary.jpg

Provider background

Specialty: Medical Oncology

Diseases treated

Education, experience and certifications
Medical Degree
Temple University School of Medicine
Residency
University of Chicago
Fellowship
Johns Hopkins University
Board Certification
Internal Medicine, 2011, Medical Oncology, 2013, American Board of Internal Medicine
Languages
English

Research

Clinical trials

We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.

Study ID:
NCT04639245
Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-small Cell Lung Cancer
Complete title
ATTAMAGE-A1.1: Phase I/II study of Autologous CD8+ and CD4+ Transgenic T cells expressing high affinity MAGE-A1-specific T-Cell Receptor (TCR) combined with Atezolizumab in patients with metastatic MAGE-A1 expressing cancer
Study ID:
NCT04242199
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
Complete title
A Phase 1 Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Select Advanced Solid Tumors
Study ID:
NCT03460977
PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Complete title
A Phase 1 Dose Escalation and Expanded Cohort Study of PF-06821497 in the Treatment of Adult Patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC), Castration Resistant Prostate Cancer (CRPC) and Follicular Lymphoma (FL)

Press

SCCA providers are often asked to give their medical expertise for press and news publications. Read articles by or about this SCCA provider.

Metastatic Prostate Cancer Paradigm Continues to Flourish With Recent Progress

SCCA's Michael Schweizer, MD, spoke with OncLive about data from three metastatic prostate cancer clinical trials.

Dr. Schweizer on the Results of the HERO Trial in Prostate Cancer

SCCA's Michael Schweizer, MD, discussed the results of the HERO trial in prostate cancer.

Your care team

At SCCA, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a team coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
Registered nurse (RN)
Your nurse manages your care alongside your physician and assists with care procedures and treatments.
Team coordinator (TC)
Your team coordinator works closely with you and your physician and serves as your scheduler.

Insurance

SCCA accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.

For providers